Clearpoint Neuro Inc

Company Profile

Clearpoint Neuro Inc had its IPO on 2020-02-12 under the ticker symbol CLPT.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Clearpoint Neuro Inc has a staff strength of 0 employees.

Stock update

Shares of Clearpoint Neuro Inc opened at $9.9 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $9.59 - $10.02, and closed at $9.69.

This is a -1.92% slip from the previous day's closing price.

A total volume of 108,404 shares were traded at the close of the day’s session.

In the last one week, shares of Clearpoint Neuro Inc have slipped by -3.1%.

Clearpoint Neuro Inc's Key Ratios

Clearpoint Neuro Inc has a market cap of $0.237 billion, indicating a price to book ratio of 5.88 and a price to sales ratio of 12.43.

In the last 12-months Clearpoint Neuro Inc’s revenue was $0.019 billion with a gross profit of $0.011 billion and an EBITDA of $-0.016 billion. The EBITDA ratio measures Clearpoint Neuro Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clearpoint Neuro Inc’s operating margin was -83.1% while its return on assets stood at -14.9% with a return of equity of -36.1%.

In Q2, Clearpoint Neuro Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 52.4%.

Clearpoint Neuro Inc’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

None

Its diluted EPS in the last 12-months stands at $-0.722 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clearpoint Neuro Inc’s profitability.

Clearpoint Neuro Inc stock is trading at a EV to sales ratio of 11.46 and a EV to EBITDA ratio of -14.1. Its price to sales ratio in the trailing 12-months stood at 12.43.

Clearpoint Neuro Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Clearpoint Neuro Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Clearpoint Neuro Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Clearpoint Neuro Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Clearpoint Neuro Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Clearpoint Neuro Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$9.69

52-Week High

$19.5

52-Week Low

$7

Analyst Target Price

$20.25

Clearpoint Neuro Inc stock is currently trading at $9.69 per share. It touched a 52-week high of $19.5 and a 52-week low of $19.5. Analysts tracking the stock have a 12-month average target price of $20.25.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.